Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors: Annals of Hematology

O. Mulas, G. Caocci, F. Stagno, M. Bonifacio, M. Annunziata, L. Luciano, E.M. Orlandi, E. Abruzzese, N. Sgherza, B. Martino, F. Albano, S. Galimberti, P. Pregno, M. Bocchia, F. Castagnetti, M. Tiribelli, G. Binotto, A. Gozzini, I. Capodanno, C. FozzaD. Luzi, F. Efficace, M.P. Simula, L. Scaffidi, F. De Gregorio, C. Elena, M.M. Trawinska, D. Cattaneo, I. Attolico, C. Baratè, F. Pirillo, A. Sicuranza, G. Gugliotta, R. Stella, E. Scalzulli, A. Iurlo, R. Foà, M. Breccia, G. La Nasa

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors: Annals of Hematology'. Together they form a unique fingerprint.

Medicine & Life Sciences